Our goal is to optimize value creation across all stages of our investment journey; from clinical trials and FDA approvals, through market validation and product adoption, to successful entry into capital markets and strategic deals.
Driving HealthTech from business plan to business success
Our unique strategic ecosystem and team’s active engagement help portfolio companies realize their full potential and achieve large-scale success. By providing unparalleled access to invaluable resources in the form of:
- Clinical infrastructures
- KOLs
- Big data
- Domain experts
- Financial backing
We help our companies gain an in-depth understanding of clinical workflows and procedures, to ensure product-market fit under challenging health economics, deliver better care for patients and create value to all stake holders.
We invest in the right fit
We invest in promising mid-to-late stage companies developing innovative platform technologies that will become the gold standard in a broad range of disciplines.
The main areas of focus include:
- Medical devices
- Diagnostics
- Digital health
- Healthcare IT
- AI and ML
We look for highly fundable companies with strong management, broad IP protection and a proven track record of execution, that are poised to benefit from the strategic synergies offered by the ALIVE ecosystem.